Literature DB >> 20935676

Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A.

I Savelyeva1, M Dobbelstein.   

Abstract

Wild-type adenovirus type 5 eliminates p53 through the E1B-55kDa and E4-34kDa gene products. Deletion or mutation of E1B-55kDa has long been thought to confer p53-selective replication of oncolytic viruses. We show here that infection with E1B-defective adenovirus mutants induces massive accumulation of p53, without obvious defects in p53 localization, phosphorylation, conformation and oligomerization. Nonetheless, p53 completely failed to induce its target genes in this scenario, for example, p21/CDKN1A, Mdm2 and PUMA. Two regions of the E1A gene products independently contributed to the suppression of p21 transcription. Depending on the E1A conserved region 3, E1B-defective adenovirus impaired the ability of the transcription factor Sp1 to bind the p21 promoter. Moreover, the amino terminal region of E1A, binding the acetyl transferases p300 and CREB-binding protein, blocked p53 K382 acetylation in infected cells. Mutating either of these E1A regions, in addition to E1B, partially restored p21 mRNA levels. Our findings argue that adenovirus attenuates p53-mediated p21 induction, through at least two E1B-independent mechanisms. Other virus species and cancer cells may employ analogous strategies to impair p53 activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20935676     DOI: 10.1038/onc.2010.461

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Acetylation is indispensable for p53 antiviral activity.

Authors:  Cesar Muñoz-Fontela; Dolores González; Laura Marcos-Villar; Michela Campagna; Pedro Gallego; José González-Santamaría; Daniel Herranz; Wei Gu; Manuel Serrano; Stuart A Aaronson; Carmen Rivas
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

2.  Impact of the adenoviral E4 Orf3 protein on the activity and posttranslational modification of p53.

Authors:  Caroline J DeHart; David H Perlman; S J Flint
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

3.  Lysine-specific post-translational modifications of proteins in the life cycle of viruses.

Authors:  Anna P Loboda; Surinder M Soond; Mauro Piacentini; Nickolai A Barlev
Journal:  Cell Cycle       Date:  2019-07-10       Impact factor: 4.534

4.  Adenovirus-based strategies enhance antitumor capability through p53-mediated downregulation of MGMT in uveal melanoma.

Authors:  Xun Li; Ling Yuan; Jianfeng Zhao; Hui Yang; Yunzhi Yang; Yanfei Zhang; Biyun Cun
Journal:  Cancer Biol Ther       Date:  2017-02-21       Impact factor: 4.742

5.  Methods for characterizing protein acetylation during viral infection.

Authors:  Laura A Murray; Ashton N Combs; Pranav Rekapalli; Ileana M Cristea
Journal:  Methods Enzymol       Date:  2019-07-18       Impact factor: 1.600

Review 6.  Histone modifiers at the crossroads of oncolytic and oncogenic viruses.

Authors:  Sara A Murphy; Norman John Mapes; Devika Dua; Balveen Kaur
Journal:  Mol Ther       Date:  2022-02-08       Impact factor: 12.910

7.  Adenovirus-mediated sensitization to the cytotoxic drugs docetaxel and mitoxantrone is dependent on regulatory domains in the E1ACR1 gene-region.

Authors:  Enrique Miranda; Hector Maya Pineda; Daniel Öberg; Gioia Cherubini; Zita Garate; Nick R Lemoine; Gunnel Halldén
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

8.  The effects of AICAR and rapamycin on mitochondrial function in immortalized mitochondrial DNA mutator murine embryonic fibroblasts.

Authors:  Vedad Delic; Kenyaria Noble; Sandra Zivkovic; Tam-Anh Phan; Christian Reynes; Yumeng Zhang; Oluwakemi Phillips; Charles Claybaker; Yen Ta; Vinh B Dinh; Josean Cruz; Tomas A Prolla; Patrick C Bradshaw
Journal:  Biol Open       Date:  2018-11-16       Impact factor: 2.422

9.  Orchestration of protein acetylation as a toggle for cellular defense and virus replication.

Authors:  L A Murray; X Sheng; I M Cristea
Journal:  Nat Commun       Date:  2018-11-23       Impact factor: 14.919

10.  A p53-independent apoptotic mechanism of adenoviral mutant E1A was involved in its selective antitumor activity for human cancer.

Authors:  Lin Fang; Qian Cheng; Jingjing Zhao; Yan Ge; Qi Zhu; Min Zhao; Jie Zhang; Qi Zhang; Liantao Li; Junjie Liu; Junnian Zheng
Journal:  Oncotarget       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.